Cargando…

A case of treatment-induced neuropathy in an adolescent with type 1 diabetes

Treatment-induced neuropathy (TIN) in diabetes is an acute and painful yet completely reversible small fiber neuropathy precipitated by a rapid improvement in glycemic control. TIN is rare in children. A 16-year-old girl developed symmetrical painful neuropathy of the foot, autonomic neuropathy, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Varadharaju, Niranjana, Jeevarathnam, Dhivyalakshmi, Rajan, Mahalakshmi, Ponnurangam Nagarajan, Vinoth, James, Saji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Pediatric Endocrinology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790869/
https://www.ncbi.nlm.nih.gov/pubmed/31607115
http://dx.doi.org/10.6065/apem.2019.24.3.203
_version_ 1783458858533912576
author Varadharaju, Niranjana
Jeevarathnam, Dhivyalakshmi
Rajan, Mahalakshmi
Ponnurangam Nagarajan, Vinoth
James, Saji
author_facet Varadharaju, Niranjana
Jeevarathnam, Dhivyalakshmi
Rajan, Mahalakshmi
Ponnurangam Nagarajan, Vinoth
James, Saji
author_sort Varadharaju, Niranjana
collection PubMed
description Treatment-induced neuropathy (TIN) in diabetes is an acute and painful yet completely reversible small fiber neuropathy precipitated by a rapid improvement in glycemic control. TIN is rare in children. A 16-year-old girl developed symmetrical painful neuropathy of the foot, autonomic neuropathy, and retinopathy 5 weeks after the diagnosis of type 1 diabetes. All causative workups were negative except for a drop-in hemoglobin A(1c) (HbA(1c)) from 17.4% to 7%, which fit with a diagnosis of TIN. Following symptomatic management, her neuropathy and retinopathy completely resolved in 2 months. Currently, she is 18 years old and doing well (HbA(1c), 7.4%) without any recurrence of TIN. TIN should be suspected in any child presenting with recent-onset type 1 diabetes and acute onset neuropathy. Our case represents an unreported scenario of the rapid progression in TIN. Awareness among clinicians about this rare but completely reversible condition is necessary to ensure proper management and adherence to glycemic control.
format Online
Article
Text
id pubmed-6790869
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Society of Pediatric Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-67908692019-10-21 A case of treatment-induced neuropathy in an adolescent with type 1 diabetes Varadharaju, Niranjana Jeevarathnam, Dhivyalakshmi Rajan, Mahalakshmi Ponnurangam Nagarajan, Vinoth James, Saji Ann Pediatr Endocrinol Metab Case Report Treatment-induced neuropathy (TIN) in diabetes is an acute and painful yet completely reversible small fiber neuropathy precipitated by a rapid improvement in glycemic control. TIN is rare in children. A 16-year-old girl developed symmetrical painful neuropathy of the foot, autonomic neuropathy, and retinopathy 5 weeks after the diagnosis of type 1 diabetes. All causative workups were negative except for a drop-in hemoglobin A(1c) (HbA(1c)) from 17.4% to 7%, which fit with a diagnosis of TIN. Following symptomatic management, her neuropathy and retinopathy completely resolved in 2 months. Currently, she is 18 years old and doing well (HbA(1c), 7.4%) without any recurrence of TIN. TIN should be suspected in any child presenting with recent-onset type 1 diabetes and acute onset neuropathy. Our case represents an unreported scenario of the rapid progression in TIN. Awareness among clinicians about this rare but completely reversible condition is necessary to ensure proper management and adherence to glycemic control. Korean Society of Pediatric Endocrinology 2019-09 2019-09-30 /pmc/articles/PMC6790869/ /pubmed/31607115 http://dx.doi.org/10.6065/apem.2019.24.3.203 Text en © 2019 Annals of Pediatric Endocrinology & Metabolism This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Varadharaju, Niranjana
Jeevarathnam, Dhivyalakshmi
Rajan, Mahalakshmi
Ponnurangam Nagarajan, Vinoth
James, Saji
A case of treatment-induced neuropathy in an adolescent with type 1 diabetes
title A case of treatment-induced neuropathy in an adolescent with type 1 diabetes
title_full A case of treatment-induced neuropathy in an adolescent with type 1 diabetes
title_fullStr A case of treatment-induced neuropathy in an adolescent with type 1 diabetes
title_full_unstemmed A case of treatment-induced neuropathy in an adolescent with type 1 diabetes
title_short A case of treatment-induced neuropathy in an adolescent with type 1 diabetes
title_sort case of treatment-induced neuropathy in an adolescent with type 1 diabetes
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790869/
https://www.ncbi.nlm.nih.gov/pubmed/31607115
http://dx.doi.org/10.6065/apem.2019.24.3.203
work_keys_str_mv AT varadharajuniranjana acaseoftreatmentinducedneuropathyinanadolescentwithtype1diabetes
AT jeevarathnamdhivyalakshmi acaseoftreatmentinducedneuropathyinanadolescentwithtype1diabetes
AT rajanmahalakshmi acaseoftreatmentinducedneuropathyinanadolescentwithtype1diabetes
AT ponnurangamnagarajanvinoth acaseoftreatmentinducedneuropathyinanadolescentwithtype1diabetes
AT jamessaji acaseoftreatmentinducedneuropathyinanadolescentwithtype1diabetes
AT varadharajuniranjana caseoftreatmentinducedneuropathyinanadolescentwithtype1diabetes
AT jeevarathnamdhivyalakshmi caseoftreatmentinducedneuropathyinanadolescentwithtype1diabetes
AT rajanmahalakshmi caseoftreatmentinducedneuropathyinanadolescentwithtype1diabetes
AT ponnurangamnagarajanvinoth caseoftreatmentinducedneuropathyinanadolescentwithtype1diabetes
AT jamessaji caseoftreatmentinducedneuropathyinanadolescentwithtype1diabetes